Filed: 8/14/2025ACC: 0001583977-25-000007
📋 What this filing means
CORMORANT ASSET MANAGEMENT, LP filed this quarterly 13F‑HR report disclosing 42 equity positions with a total reported market value of $1.34B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
42
Positions
$1.34B
Total AUM (reported)
75.01M
Total Shares
Allocation by class
COM$469.36M35.0%
CLASS A ORD$400.92M29.9%
COM NEW$193.59M14.4%
SPONSORED ADS$76.82M5.7%
ORDINARY SHARES$63.88M4.8%
COM PAR $.01$54.35M4.0%
COMMON STOCK$52.68M3.9%
Portfolio Concentration
Top 3$548.35M40.8%
4–10$364.05M27.1%
11–25$322.34M24.0%
Rest$107.74M8.0%
Top 3 weight
40.8%
Top 10 weight
68.0%
Voting Authority Distribution
Total shares with voting rights: 75.01M
Sole
Full voting authority
75.01M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other42
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings42
Rows:
MOONLAKE IMMUNOTHERAPEUTICS
DFNDShares8.49M
TypeSH
Market value$400.92M
29.86%
Sole
8.49M
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
DFNDShares8.32M
TypeSH
Market value$78.34M
5.84%
Sole
8.32M
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
DFNDShares1.60M
TypeSH
Market value$69.09M
5.15%
Sole
1.60M
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
DFNDShares1.63M
TypeSH
Market value$68.33M
5.09%
Sole
1.63M
Shared
0.00
None
0.00
MERUS N V
DFNDShares1.12M
TypeSH
Market value$58.91M
4.39%
Sole
1.12M
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
DFNDShares4.25M
TypeSH
Market value$55.74M
4.15%
Sole
4.25M
Shared
0.00
None
0.00
INSMED INC
DFNDShares540K
TypeSH
Market value$54.35M
4.05%
Sole
540K
Shared
0.00
None
0.00
ARCELLX INC
DFNDShares800K
TypeSH
Market value$52.68M
3.92%
Sole
800K
Shared
0.00
None
0.00
NEWAMSTERDAM PHARMA COMPANY
DFNDShares2.17M
TypeSH
Market value$39.39M
2.93%
Sole
2.17M
Shared
0.00
None
0.00
JANUX THERAPEUTICS INC
DFNDShares1.50M
TypeSH
Market value$34.65M
2.58%
Sole
1.50M
Shared
0.00
None
0.00
RAPPORT THERAPEUTICS INC
DFNDShares2.94M
TypeSH
Market value$33.44M
2.49%
Sole
2.94M
Shared
0.00
None
0.00
VERONA PHARMA PLC
DFNDShares350K
TypeSH
Market value$33.10M
2.47%
Sole
350K
Shared
0.00
None
0.00
HELIX ACQUISITION CORP II
DFNDShares2.91M
TypeSH
Market value$30.89M
2.30%
Sole
2.91M
Shared
0.00
None
0.00
BRIGHT MINDS BIOSCIENCES INC
DFNDShares1.06M
TypeSH
Market value$27.66M
2.06%
Sole
1.06M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
DFNDShares2.09M
TypeSH
Market value$27.42M
2.04%
Sole
2.09M
Shared
0.00
None
0.00
PHARVARIS N V
DFNDShares1.45M
TypeSH
Market value$25.60M
1.91%
Sole
1.45M
Shared
0.00
None
0.00
GH RESEARCH PLC
DFNDShares2.01M
TypeSH
Market value$24.50M
1.82%
Sole
2.01M
Shared
0.00
None
0.00
ARS PHARMACEUTICALS INC
DFNDShares1.10M
TypeSH
Market value$19.20M
1.43%
Sole
1.10M
Shared
0.00
None
0.00
CORBUS PHARMACEUTICALS HLDGS
DFNDShares2.38M
TypeSH
Market value$16.39M
1.22%
Sole
2.38M
Shared
0.00
None
0.00
ABIVAX SA
DFNDShares2.13M
TypeSH
Market value$16.29M
1.21%
Sole
2.13M
Shared
0.00
None
0.00
CG ONCOLOGY INC
DFNDShares625K
TypeSH
Market value$16.25M
1.21%
Sole
625K
Shared
0.00
None
0.00
ARCUTIS BIOTHERAPEUTICS INC
DFNDShares1M
TypeSH
Market value$14.02M
1.04%
Sole
1M
Shared
0.00
None
0.00
CARGO THERAPEUTICS INC
DFNDShares3.38M
TypeSH
Market value$13.93M
1.04%
Sole
3.38M
Shared
0.00
None
0.00
TARSUS PHARMACEUTICALS INC
DFNDShares300K
TypeSH
Market value$12.15M
0.91%
Sole
300K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
DFNDShares400K
TypeSH
Market value$11.50M
0.86%
Sole
400K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
MOONLAKE IMMUNOTHERAPEUTICSDFND | CLASS A ORD | 8.49M | SH | $400.92M 29.86% | 8.49M | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCDFND | COM NEW | 8.32M | SH | $78.34M 5.84% | 8.32M | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCDFND | COM | 1.60M | SH | $69.09M 5.15% | 1.60M | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES IDFND | COM NEW | 1.63M | SH | $68.33M 5.09% | 1.63M | 0.00 | 0.00 |
MERUS N VDFND | COM | 1.12M | SH | $58.91M 4.39% | 1.12M | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCDFND | COM | 4.25M | SH | $55.74M 4.15% | 4.25M | 0.00 | 0.00 |
INSMED INCDFND | COM PAR $.01 | 540K | SH | $54.35M 4.05% | 540K | 0.00 | 0.00 |
ARCELLX INCDFND | COMMON STOCK | 800K | SH | $52.68M 3.92% | 800K | 0.00 | 0.00 |
NEWAMSTERDAM PHARMA COMPANYDFND | ORDINARY SHARES | 2.17M | SH | $39.39M 2.93% | 2.17M | 0.00 | 0.00 |
JANUX THERAPEUTICS INCDFND | COM | 1.50M | SH | $34.65M 2.58% | 1.50M | 0.00 | 0.00 |
RAPPORT THERAPEUTICS INCDFND | COM | 2.94M | SH | $33.44M 2.49% | 2.94M | 0.00 | 0.00 |
VERONA PHARMA PLCDFND | SPONSORED ADS | 350K | SH | $33.10M 2.47% | 350K | 0.00 | 0.00 |
HELIX ACQUISITION CORP IIDFND | CL A ORD SHS | 2.91M | SH | $30.89M 2.30% | 2.91M | 0.00 | 0.00 |
BRIGHT MINDS BIOSCIENCES INCDFND | COM NEW | 1.06M | SH | $27.66M 2.06% | 1.06M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCDFND | SPONSORED ADS | 2.09M | SH | $27.42M 2.04% | 2.09M | 0.00 | 0.00 |
PHARVARIS N VDFND | COM | 1.45M | SH | $25.60M 1.91% | 1.45M | 0.00 | 0.00 |
GH RESEARCH PLCDFND | ORDINARY SHARES | 2.01M | SH | $24.50M 1.82% | 2.01M | 0.00 | 0.00 |
ARS PHARMACEUTICALS INCDFND | COM | 1.10M | SH | $19.20M 1.43% | 1.10M | 0.00 | 0.00 |
CORBUS PHARMACEUTICALS HLDGSDFND | COM NEW | 2.38M | SH | $16.39M 1.22% | 2.38M | 0.00 | 0.00 |
ABIVAX SADFND | SPONSORED ADS | 2.13M | SH | $16.29M 1.21% | 2.13M | 0.00 | 0.00 |
CG ONCOLOGY INCDFND | COM | 625K | SH | $16.25M 1.21% | 625K | 0.00 | 0.00 |
ARCUTIS BIOTHERAPEUTICS INCDFND | COM | 1M | SH | $14.02M 1.04% | 1M | 0.00 | 0.00 |
CARGO THERAPEUTICS INCDFND | COM | 3.38M | SH | $13.93M 1.04% | 3.38M | 0.00 | 0.00 |
TARSUS PHARMACEUTICALS INCDFND | COM | 300K | SH | $12.15M 0.91% | 300K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INDFND | COM | 400K | SH | $11.50M 0.86% | 400K | 0.00 | 0.00 |
Page 1 of 2